Now showing items 1-5 of 5

    • Mendoza Naranjo, Ariadna; Sáez, Pablo J.; Johansson, C. Christian; Ramírez Fernández, Marcos; Mandakovic Seyler, Dinka; Pereda, Cristián; López Nitsche, Mercedes; Kiessling, Rolf; Sáez, Juan C.; Salazar Onfray, Flavio (2007)
      Previously, we found that human dendritic cells (hDCs) pulsed with a melanoma cell lysate (MCL) and stimulated with TNF-ce (MCL/TNF) acquire a mature phenotype in vitro and are able to trigger tumor-specific immune responses ...
    • Aguilera, Raquel; Saffie, Carlos; Tittarelli, Andrés; González Bergas, Fermín; Ramírez Fernández, Marcos; Reyes, Diego; Pereda, Cristián; Hevia, Daniel; García, Tamara; Salazar, Lorena; Ferreira Vigouroux, Luis Arturo; Hermoso Ramello, Marcela; Mendoza Naranjo, Ariadna; Ferrada, Carlos; Garrido, Paola; López Nitsche, Mercedes; Salazar Onfray, Flavio (AMER ASSOC CANCER RESEARCH, 2011-04-15)
      Purpose: This study characterizes, biologically and clinically, a novel type of dendritic cells (DC) produced in the short term and called tumor antigen–presenting cells (TAPCells). In particular, we identified factors ...
    • Durán Aniotz, Claudia; Segal, Gabriela; Salazar, Lorena; Pereda, Cristián; Falcón, Cristián; Tempio, Fabián; Aguilera, Raquel; González González, Rodrigo; Pérez Núñez, Claudio; Tittarelli, Andrés; Catalán Martina, Diego; Nervi, Bruno; Larrondo Lillo, Milton; Salazar Onfray, Flavio; López Nitsche, Mercedes (Springer, 2013)
      Introduction Immunization with autologous dendritic cells (DCs) loaded with a heat shock-conditioned allogeneic melanoma cell lysate caused lysate-specific delayed type hypersensitivity (DTH) reactions in a number ...
    • González Bergas, Fermín; Ortiz, Carolina; Reyes Rojas, Montserrat; Dutzan Muñoz, Nicolás; Patel, Vyomesh; Pereda, Cristián; Gleisner Muñoz, María Alejandra; López Nitsche, Mercedes; Gutkind, J. Silvio; Salazar Onfray, Flavio (John Wiley & Sons Ltd,, 2014)
      We have previously reported a novel method for the production of tumour-antigen-presenting cells (referred to as TAPCells) that are currently being used in cancer therapy, using an allogeneic melanomaderived cell lysate ...
    • González, Fermin E.; Chernobrovkin, Alexey; Pereda, Cristián; García Salum, Tamara; López, Mercedes N.; Salazar Onfray, Flavio; Zubarev, Roman A.; Tittarelli, Andrés (Hindawi, 2018)
      Autologous dendritic cells (DCs) loaded with cancer cell-derived lysates have become a promising tool in cancer immunotherapy. During the last decade, we demonstrated that vaccination of advanced melanoma patients with ...